Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov site revision identifier in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check16 days agoChange DetectedA sitewide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology and provides links to updates and FAQs.SummaryDifference0.5%

- Check23 days agoChange DetectedThe website’s footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.7.0 was added to the record history. The previous revision v3.6.6 was removed, updating the page’s revision log to reflect the latest version.SummaryDifference0.1%

- Check72 days agoChange DetectedThe revision history now includes a new entry for v3.6.6 and removes the prior v3.6.5 from the list, reflecting the latest release trace for the study record.SummaryDifference0.1%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.